APA (7th ed.) Citation

Poordad, F., Landis, C. S., Asatryan, A., Jackson, D. F., Ng, T. I., Fu, B., . . . Kort, J. (2016). High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection. Liver International, 36(8), 1125. https://doi.org/10.1111/liv.13067

Chicago Style (17th ed.) Citation

Poordad, Fred, Charles S. Landis, Armen Asatryan, Daniel F. Jackson, Teresa I. Ng, Bo Fu, Chih ‐ Wei Lin, Betty Yao, and Jens Kort. "High Antiviral Activity of NS5A Inhibitor ABT-530 with Paritaprevir/ritonavir and Ribavirin Against Hepatitis C Virus Genotype 3 Infection." Liver International 36, no. 8 (2016): 1125. https://doi.org/10.1111/liv.13067.

MLA (9th ed.) Citation

Poordad, Fred, et al. "High Antiviral Activity of NS5A Inhibitor ABT-530 with Paritaprevir/ritonavir and Ribavirin Against Hepatitis C Virus Genotype 3 Infection." Liver International, vol. 36, no. 8, 2016, p. 1125, https://doi.org/10.1111/liv.13067.